News
ASPHF
8.48
NaN%
--
Weekly Report: what happened at ASPHF last week (0908-0912)?
Weekly Report · 09/15/2025 11:44
Weekly Report: what happened at ASPHF last week (0901-0905)?
Weekly Report · 09/08/2025 11:46
Weekly Report: what happened at ASPHF last week (0825-0829)?
Weekly Report · 09/01/2025 11:40
Weekly Report: what happened at ASPHF last week (0818-0822)?
Weekly Report · 08/25/2025 11:54
Ascentage Pharma Group International GAAP EPS of -$0.24, revenue of $32.6M
Seeking Alpha · 08/21/2025 16:33
Weekly Report: what happened at ASPHF last week (0811-0815)?
Weekly Report · 08/18/2025 11:44
Weekly Report: what happened at ASPHF last week (0804-0808)?
Weekly Report · 08/11/2025 11:53
Weekly Report: what happened at ASPHF last week (0728-0801)?
Weekly Report · 08/04/2025 11:56
Weekly Report: what happened at ASPHF last week (0721-0725)?
Weekly Report · 07/28/2025 11:57
Weekly Report: what happened at ASPHF last week (0714-0718)?
Weekly Report · 07/21/2025 11:45
Weekly Report: what happened at ASPHF last week (0707-0711)?
Weekly Report · 07/14/2025 11:56
Ascentage Pharma appoints Veet Misra as CFO
Seeking Alpha · 07/08/2025 05:37
Weekly Report: what happened at ASPHF last week (0630-0704)?
Weekly Report · 07/07/2025 11:46
Weekly Report: what happened at ASPHF last week (0623-0627)?
Weekly Report · 06/30/2025 11:54
Weekly Report: what happened at ASPHF last week (0616-0620)?
Weekly Report · 06/23/2025 11:44
Weekly Report: what happened at ASPHF last week (0609-0613)?
Weekly Report · 06/16/2025 11:53
Weekly Report: what happened at ASPHF last week (0602-0606)?
Weekly Report · 06/09/2025 11:55
Weekly Report: what happened at ASPHF last week (0526-0530)?
Weekly Report · 06/02/2025 12:05
Weekly Report: what happened at ASPHF last week (0519-0523)?
Weekly Report · 05/26/2025 12:04
Weekly Report: what happened at ASPHF last week (0512-0516)?
Weekly Report · 05/19/2025 11:52
More
Webull provides a variety of real-time ASPHF stock news. You can receive the latest news about Ascentage Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ASPHF
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.